Hikma Pharmaceuticals PLC Revenue and Competitors
Estimated Revenue & Valuation
- Hikma Pharmaceuticals PLC's estimated annual revenue is currently $2B per year.
- Hikma Pharmaceuticals PLC's estimated revenue per employee is $201,000
Employee Data
- Hikma Pharmaceuticals PLC has 10087 Employees.
- Hikma Pharmaceuticals PLC grew their employee count by 6% last year.
Hikma Pharmaceuticals PLC's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Corporate VP Technical Affairs | Reveal Email/Phone |
2 | Associate VP, Head R&D and 3rd Party Quality Operations | Reveal Email/Phone |
3 | Associate VP -- IP and Litigation Counsel, North America | Reveal Email/Phone |
4 | Executive Assistant to VP, Research & Development, Hikma Pharmaceuticals | Reveal Email/Phone |
5 | Associate VP, Production, Engineering and Maintenance | Reveal Email/Phone |
6 | CFO | Reveal Email/Phone |
7 | Chief Counsel and Company Secretary | Reveal Email/Phone |
8 | Head Communications and Government Affairs, North America | Reveal Email/Phone |
9 | Head Biosimilar Development | Reveal Email/Phone |
10 | Head Commercial Operations | Reveal Email/Phone |
Hikma Pharmaceuticals PLC Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $145.7M | 505 | 0% | $122.8M | N/A |
What Is Hikma Pharmaceuticals PLC?
Hikma helps put better health within reach every day for millions of people in more than 50 countries around the world. For 40 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We're a global company with a local presence across the United States (US), the Middle East and North Africa (MENA) and Europe, and we use our unique insight and expertise to transform cutting-edge science into innovative solutions that transform people's lives. We're committed to our customers, and the people they care for, and by thinking creatively and acting practically, we provide them with a broad range of branded and non-branded generic medicines. Together, our 8,500 colleagues are helping to shape a healthier world that enriches all our communities. We are a leading licensing partner in the MENA region, and through our venture capital arm, are helping bring innovative health technologies to people around the world.
keywords:N/A
N/A
Total Funding
10087
Number of Employees
$2B
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Hikma Pharmaceuticals PLC News
LONDON, April 21, 2022 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announces that it...
The Federal Trade Commission today required as a condition of Hikma Pharmaceuticals PLC's $375 million acquisition of Custopharm,...
AMMAN, Jordan, March 28, 2022 /PRNewswire/ -- Hikma Pharmaceuticals PLC ('Hikma' or 'Group'), the multinational pharmaceutical company,...
LONDON, Aug. 4, 2021 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces the launch of KLOXXADO™ (naloxone HCl) nasal spray 8mg in the US. KLOXXADO™ was approved by the US Food and Drug Administration (FDA) in April 2021 for the emergency trea ...
LONDON, June 9, 2021 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces that Patrick Genestin has been appointed Vice President, Business Development, Generics. Mr. Genestin brings to Hikma more than 25 years of experience in the pharmaceutic ...